Product Description
1.Product name:Fructose sodium diphoshate for injection
2.Specification:5g
3.Package:1 vial/box
4.Shelf life:36 months
5.Registration documents are available.
If you are interested in our products,ple feel free to contact us.
AI Product Description
*The following content is generated by AI and is for reference only.
Fructose Sodium Diphosphate for Injection is a specialized pharmaceutical intermediate and active ingredient primarily utilized in clinical settings to manage metabolic disorders and support energy metabolism. Chemically, this compound represents the sodium salt of fructose diphosphoric acid, serving as a critical precursor in glycolysis and gluconeogenesis pathways. Its molecular formula is typically denoted as C₆H₁₀Na₂O₁₂P₂, reflecting its structure comprising a fructose backbone linked to two phosphate groups neutralized by sodium ions. The specific CAS number associated with this substance is 30217-59-9, which distinguishes it from other sugar phosphates in regulatory databases and ensures precise identification during manufacturing and quality control processes.
The primary therapeutic application of Fructose Sodium Diphosphate for Injection lies in its ability to enhance cellular ATP production. By bypassing the rate-limiting step of glycolysis catalyzed by phosphofructokinase, it provides an immediate source of high-energy phosphate compounds, thereby accelerating energy recovery in hypoxic or ischemic tissues. Consequently, it is frequently employed in the adjunctive treatment of conditions such as acute myocardial infarction, severe liver dysfunction, and chronic fatigue syndromes where cellular energy depletion is a significant factor. Furthermore, its role extends to improving microcirculation and reducing edema in various organ systems due to its osmotic properties and metabolic benefits.
In the pharmaceutical industry, this injectable solution must adhere to strict sterility and purity standards defined by pharmacopoeias like the USP or EP. It is administered intravenously under controlled medical supervision to ensure rapid bioavailability and minimize adverse reactions. While generally well-tolerated, dosage regimens are carefully calibrated based on patient weight and clinical status to prevent electrolyte imbalances. As research into metabolic modulation continues, Fructose Sodium Diphosphate remains a vital tool in modern integrative medicine, bridging the gap between biochemical theory and effective clinical intervention for patients suffering from complex metabolic stress. Its unique chemical stability and efficacy make it an indispensable component in emergency care and intensive therapy protocols worldwide.